What causes atrial myxoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Causes Atrial Myxoma?

Atrial myxomas are benign primary cardiac tumors whose exact cause remains largely unknown, though they arise from primitive multipotent mesenchymal cells in the endocardium, with approximately 90% occurring sporadically and 10% having a familial autosomal dominant inheritance pattern. 1, 2

Sporadic Atrial Myxomas (90% of cases)

The vast majority of atrial myxomas occur without identifiable genetic or environmental triggers. 3

  • Origin: These tumors develop from primitive mesenchymal cells within the endocardium, most commonly at the fossa ovalis region of the interatrial septum 4, 5
  • Location pattern: Approximately 75% occur in the left atrium, 10-20% in the right atrium, and the remainder in atypical locations including ventricular chambers 5, 6
  • Incidence: Autopsy series demonstrate an occurrence rate of 0.02% in the general population, making them the most common primary cardiac tumor 2, 4

Familial Atrial Myxomas (10% of cases)

A distinct subset of patients develops myxomas through autosomal dominant inheritance, often as part of familial syndromes. 1, 3

  • Genetic transmission: Several chromosomal loci have been identified in familial cases, transmitted as an autosomal dominant trait 1
  • Associated syndromes: Atrial myxomas occur with increased frequency in patients with familial multiple neoplasia and lentiginosis syndrome (Carney complex) 1
  • Clinical implications: Familial cases typically present at younger ages, involve multiple cardiac chambers simultaneously, and have significantly higher recurrence rates (up to 20%) compared to sporadic cases (1-5%) 4, 3

Pathophysiological Development

The microscopic architecture reveals the tumor's mesenchymal origin with characteristic myxoid matrix proliferation. 4

  • Cellular composition: Myxomas contain lepidic cells (polygonal to stellate-shaped with eosinophilic cytoplasm), stromal spindle cells, and endothelial-lined vascular channels embedded in abundant mucopolysaccharide-rich myxoid matrix 4
  • Growth pattern: The tumor typically attaches to the atrial septum via a stalk, though 10% arise from other sites including the posterior wall, anterior wall, or atrial appendages 5, 7
  • Surface characteristics: Villous or papillary surface architecture correlates with higher embolic potential, as these friable surfaces readily generate thrombus or tumor fragments 2, 4

Associated Conditions (Not Causative)

While certain conditions may coexist with atrial myxomas, they do not cause the tumor:

  • Structural heart disease: Atrial myxomas can occur alongside atrial septal defects, though this represents coincidental occurrence rather than causation 7
  • Cardiomyopathy: Isolated case reports describe myxomas in patients with hypertrophic cardiomyopathy, but no causal relationship exists 8

Critical Clinical Pitfall

Do not confuse conditions that predispose to atrial fibrillation (valvular disease, hypertension, heart failure) with causes of atrial myxoma—these are entirely separate pathophysiological entities. 9 The evidence regarding atrial fibrillation mechanisms 1 and mitral valve prolapse pathology 1 is irrelevant to myxoma etiology.

Screening Recommendations

First-degree relatives of patients with documented atrial myxomas must undergo echocardiographic screening for occult tumors, given the 10% familial inheritance pattern. 3

  • Transthoracic echocardiography provides 95% sensitivity for detection 3
  • Transesophageal echocardiography approaches 100% sensitivity and should be used when transthoracic imaging is inconclusive 4, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Surgical Management of Cardiac Myxoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Atrial myxoma: case report and a review of the literature.

Heart disease (Hagerstown, Md.), 2003

Guideline

Diagnosis and Management of Left Atrial Mass with Syncope

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Atrial myxoma: trends in management.

International journal of health sciences, 2008

Research

Atrial myxoma in a patient with hypertrophic cardiomyopathy.

Texas Heart Institute journal, 2013

Guideline

Atrial Fibrillation Causes and Risk Factors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.